Emergent BioSolutions Receives FDA Approval to Manufacture ACAM2000 at Canton, Massachusetts Facility

Source :: Plus Company Updates. November 23, 2017
Publication Year :: 2017
Abstract: GAITHERSBURG: Emergent BioSolutions has issued the following news release: Emergent BioSolutions Inc. (NYSE:EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application [...]

Subjects :: United States. Food and Drug Administration
Smallpox -- Health aspects
Smallpox vaccines -- Health aspects
Drug approval -- Health aspects
General interest
News, opinion and commentary
ACAM2000 (Vaccine) -- Health aspects

Tools